The international collaborative study of maternal phenylketonuria: status report 1994

Acta Pædiatrica

Volumn 83, Issue , 1994, Pages 111-119

  Koch, R ^a   Levy, HL ^b,j   Matalon, R ^c   Rouse, B ^d,k   Hanley, WB ^e,l   Trefz, F ^f   Azen, C ^a   Friedan, EG ^a   de la Cruz, F ^g   Guttler F ^h   Acosta, PB ^i,m  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Boston Biomedical   (United States)

^d MIAMI CHILDREN'S HOSPITAL   (United States)

^e Universität Tübingen ^*  (United States)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h University of Copenhagen ^*  (United States)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^l HOSPITAL FOR SICK CHILDREN   (Canada)

^m ABBOTT LABORATORIES   (United States)

more..

Author keywords

Congenital heart disease; fetal abnormalities; microcephaly; phenylketonuria; pregnancy

Indexed keywords

ADULT; CONFERENCE PAPER; CONGENITAL HEART DISEASE; DIET; FETUS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MICROCEPHALY; NEWBORN; PHENYLKETONURIA; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; ARTICLE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FEMALE; INTERNATIONAL COOPERATION; MULTICENTER STUDY; PREGNANCY OUTCOME; PROSPECTIVE STUDY;

PHENYLALANINE;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERNATIONAL COOPERATION; PHENYLALANINE; PHENYLKETONURIA, MATERNAL; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 0028695286     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1994.tb13468.x     Document Type: Article

References (19)

1. Influence of phenylalanine intake on phenylketonuria
2. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants
3. Maternal phenylketonuria and hyperphenylalaninemia: an international survey of the outcome of untreated and treated pregnancies
4. A preliminary report of the collaborative study of maternal phenylketonuria in the United States and Canada
5. The North American collaborative study of maternal phenylketonuria: status report 1993
6. Mendelian hyperphenylalaninemia
7. Maternal phenylketonuria collaborative study, obstetric aspects and outcome: the first 6 years
8. Intrauterine growth as estimated from liveborn birth‐weight data at 24 to 42 weeks of gestation
9. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks
10. Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations
11. Projections of a rebound in frequency of mental retardation from phenylketonuria
12. Reproductive counseling for adolescent females with phenylketonuria
13. Psychosocial factors in maternal phenylketonuria: prevention of unplanned pregnancies
14. Diet policies of PKU clinics in the United States
15. Timing of strict diet in relation to fetal damage in maternal phenylketonuria
16. Effects of untreated maternal hyperphenylalaninemia on the fetus: further study families identified by cord blood screening
17. Maternal phenylketonuria (PKU): a review
18. Maternal phenylketonuria and hyperphenylalaninemia: implications for medical practice in the United States
19. Preventing birth defects from maternal phenylketonuria